192 related articles for article (PubMed ID: 19763432)
1. Biomarker targets and novel therapeutics.
Clouser M; Hess LM; Chambers SK
Cancer Treat Res; 2009; 149():85-105. PubMed ID: 19763432
[No Abstract] [Full Text] [Related]
2. Novel therapeutic targets.
Farley J; Birrer MJ
Cancer Treat Res; 2009; 149():63-84. PubMed ID: 19763431
[No Abstract] [Full Text] [Related]
3. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients.
Marchetti C; Palaia I; De Felice F; Musella A; Donfracesco C; Vertechy L; Romito A; Piacenti I; Musio D; Muzii L; Tombolini V; Benedetti Panici P
Cancer Treat Rev; 2016 Jan; 42():41-6. PubMed ID: 26559739
[TBL] [Abstract][Full Text] [Related]
5. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
Rowinsky EK
J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
[TBL] [Abstract][Full Text] [Related]
6. Current overview of angiogenesis inhibitors.
Ellis LM
Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
[No Abstract] [Full Text] [Related]
7. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
8. [Use of new molecules in the treatment of advanced thyroid cancer].
Galofré JC; Gómez-Sáez JM; Álvarez Escola C; Álvarez García E; Anda Apiñaniz E; Calleja A; Donnay S; Lucas-Martin A; Menéndez Torre E; Navarro González E; Pereg V; Pérez Corral B; Santamaría Sandi J; Riesco Eizaguirre G; Zafón Llopis C;
Endocrinol Nutr; 2011 Oct; 58(8):381-6. PubMed ID: 21924966
[No Abstract] [Full Text] [Related]
9. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.
Bao T; Smith BD; Karp JE
Clin Adv Hematol Oncol; 2005 Apr; 3(4):287-96, 302. PubMed ID: 16167001
[TBL] [Abstract][Full Text] [Related]
10. Targeted cancer therapy: promise and reality.
Klein S; Levitzki A
Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
12. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
13. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
14. Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming?
Santoni M; Rizzo M; Burattini L; Berardi R; Carteni G; Cascinu S
Curr Cancer Drug Targets; 2013 Mar; 13(3):313-25. PubMed ID: 23190497
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
Carella AM
Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645
[No Abstract] [Full Text] [Related]
16. New therapeutic targets in melanoma.
Martí RM; Sorolla A; Yeramian A
Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672
[TBL] [Abstract][Full Text] [Related]
17. Emerging targeted therapies for bladder cancer: a disease waiting for a drug.
Dovedi SJ; Davies BR
Cancer Metastasis Rev; 2009 Dec; 28(3-4):355-67. PubMed ID: 19997963
[TBL] [Abstract][Full Text] [Related]
18. [The pathologist and targeted therapies in oncology].
Bertheau P
Ann Pathol; 2009 Nov; 29 Spec No 1():S69-70. PubMed ID: 19887258
[No Abstract] [Full Text] [Related]
19. Kinases as targets in the treatment of solid tumors.
Giamas G; Man YL; Hirner H; Bischof J; Kramer K; Khan K; Ahmed SS; Stebbing J; Knippschild U
Cell Signal; 2010 Jul; 22(7):984-1002. PubMed ID: 20096351
[TBL] [Abstract][Full Text] [Related]
20. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
